You have accessRestricted access
AmbOx trial: does ambulatory oxygen improve quality of life in patients with fibrotic interstitial lung disease?
DinaVisca,LetiziaMori,VickyTsipouri,SaraCanu,MatteoBonini,MattPavitt,SharonFleming,AshiFirouzi,MoragFarquhar,ElizabethLeung,CharlotteHogben,AngeloDe Lauretis,MariaKokosi,John TayuLee,Rosemary•莱恩,NaomiRippon,AlfredoChetta,Anne MarieRussell,PeterSaunders,VasilisKouranos,GiorgiosMargaritopoulos,Toby MMaher,AnnaStockford,Timothy PaulCullinan,NickHopkins,SurinderBirring,Athol UWells,JenniferWhitty,WinstonBanya,HuzaifaAdamali,LisaSpencer,ElisabettaRenzoni,PiersanteSestini
European Respiratory Journal
50
(suppl 61)
PA2961;
DOI:10.1183/1393003.congress-2017.PA2961
Published 6 December 2017